Atossa Therapeutics (ATOS) Q4 2025 Earnings Report
MX:ATOS Q4 2025 EPS Results
- Actual EPS
- -MXN 22.11
- Consensus EPS
- -MXN 21.14
- Beat/Miss
- Missed by -MXN 0.97
- One Year Ago EPS
- -MXN 11.15
MX:ATOS Q4 2025 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- MXN 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 03/25/2026
- Time
- After Close
- Conference Call
- Wednesday, March 25, 2026
MX:ATOS Upcoming Earnings
Atossa Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ATOS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -15.92- | -19.51 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | -19.05-17.65 | -19.51 | 9.52% (+1.86) | |
| May 08, 2026 | 2026 (Q1) | -18.39-20.62 | -13.94 | -48.00% (-6.69) | |
| Mar 25, 2026 | 2025 (Q4) | -21.14-22.11 | -11.15 | -98.33% (-10.96) | |
| Nov 12, 2025 | 2025 (Q3) | -18.12-19.51 | -16.72 | -16.67% (-2.79) | |
| Aug 12, 2025 | 2025 (Q2) | -16.02-19.51 | -13.94 | -40.00% (-5.57) | |
| May 13, 2025 | 2025 (Q1) | -15.79-13.94 | -13.94 | 0.00% (+0.00) | |
| Mar 25, 2025 | 2024 (Q4) | -17.65-11.15 | -16.72 | 33.33% (+5.57) | |
| Nov 12, 2024 | 2024 (Q3) | -16.72-16.72 | -13.94 | -20.00% (-2.79) | |
| Aug 12, 2024 | 2024 (Q2) | -16.72-13.94 | -22.3 | 37.50% (+8.36) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
